申请人:CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
公开号:EP3686199A1
公开(公告)日:2020-07-29
Disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and an application of the compound or slat in preparation of drugs for treating diseases related to an A2A receptor.
公开了一种由式(I)代表的化合物或其药学上可接受的盐,以及该化合物或板条在制备治疗与 A2A 受体有关的疾病的药物中的应用。